These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34314501)

  • 1. Safety and Effectiveness of Intravenous Artesunate for Treatment of Severe Malaria in the United States-April 2019 Through December 2020.
    Abanyie F; Acharya SD; Leavy I; Bowe M; Tan KR
    Clin Infect Dis; 2021 Dec; 73(11):1965-1972. PubMed ID: 34314501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-artesunate Delayed Hemolysis in Patients With Severe Malaria in the United States-April 2019 Through July 2021.
    Abanyie F; Ng J; Tan KR
    Clin Infect Dis; 2023 Feb; 76(3):e857-e863. PubMed ID: 36052468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Artesunate for the Treatment of Severe and Complicated Malaria in the United States: Clinical Use Under an Investigational New Drug Protocol.
    Twomey PS; Smith BL; McDermott C; Novitt-Moreno A; McCarthy W; Kachur SP; Arguin PM
    Ann Intern Med; 2015 Oct; 163(7):498-506. PubMed ID: 26301474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial.
    Byakika-Kibwika P; Nyakato P; Lamorde M; Kiragga AN
    Malar J; 2018 Oct; 17(1):400. PubMed ID: 30376860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed haemolysis after artesunate therapy in a cohort of patients with severe imported malaria due to Plasmodium falciparum.
    Gómez-Junyent J; Ruiz-Panales P; Calvo-Cano A; Gascón J; Muñoz J
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):516-519. PubMed ID: 26708338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Artesunate for Imported Severe Malaria in Children Treated in Four Tertiary Care Centers in Germany: A Retrospective Study.
    Bélard S; Brand J; Schulze-Sturm U; Janda A; von Both U; Tacoli C; Alberer M; Kempf C; Stegemann MS; Krüger R; Varnholt V; Blohm M; Reiter K; Zoller T; Suttorp N; Mall M; von Bernuth H; Gratopp A; Hübner J; Hufnagel M; Kobbe R; Kurth F
    Pediatr Infect Dis J; 2019 Nov; 38(11):e295-e300. PubMed ID: 31626041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia.
    Rolling T; Schmiedel S; Wichmann D; Wittkopf D; Burchard GD; Cramer JP
    Malar J; 2012 May; 11():169. PubMed ID: 22594446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
    Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW
    Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
    Das D; Tripura R; Phyo AP; Lwin KM; Tarning J; Lee SJ; Hanpithakpong W; Stepniewska K; Menard D; Ringwald P; Silamut K; Imwong M; Chotivanich K; Yi P; Day NP; Lindegardh N; Socheat D; Nguon C; White NJ; Nosten F; Dondorp AM
    Clin Infect Dis; 2013 Mar; 56(5):e48-58. PubMed ID: 23175556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous artesunate for severe malaria in travelers, Europe.
    Zoller T; Junghanss T; Kapaun A; Gjorup I; Richter J; Hugo-Persson M; Mørch K; Foroutan B; Suttorp N; Yürek S; Flick H
    Emerg Infect Dis; 2011 May; 17(5):771-7. PubMed ID: 21529383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artesunate: investigational drug for the treatment of severe falciparum malaria in Hawai'i.
    Callender DM; Hsue G
    Hawaii Med J; 2011 Apr; 70(4):77-9. PubMed ID: 21785506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
    Pryce J; Hine P
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD006404. PubMed ID: 30620055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
    Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
    Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia.
    Watts RE; Odedra A; Marquart L; Webb L; Abd-Rahman AN; Cascales L; Chalon S; Rebelo M; Pava Z; Collins KA; Pasay C; Chen N; Peatey CL; Möhrle JJ; McCarthy JS
    PLoS Med; 2020 Aug; 17(8):e1003203. PubMed ID: 32822347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials.
    Duparc S; Borghini-Fuhrer I; Craft CJ; Arbe-Barnes S; Miller RM; Shin CS; Fleckenstein L
    Malar J; 2013 Feb; 12():70. PubMed ID: 23433102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of artesunate and quinine in the treatment of severe Plasmodium falciparum malaria at Kassala hospital, Sudan.
    Abdallah TM; Elmardi KA; Elhassan AH; Omer MB; Elhag MS; Desogi MA; Siddig MF; Adam I
    J Infect Dev Ctries; 2014 May; 8(5):611-5. PubMed ID: 24820465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies.
    Gomes M; Ribeiro I; Warsame M; Karunajeewa H; Petzold M
    BMC Infect Dis; 2008 Mar; 8():39. PubMed ID: 18373841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deaths due to Plasmodium knowlesi malaria in Sabah, Malaysia: association with reporting as Plasmodium malariae and delayed parenteral artesunate.
    Rajahram GS; Barber BE; William T; Menon J; Anstey NM; Yeo TW
    Malar J; 2012 Aug; 11():284. PubMed ID: 22905799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous artesunate plus oral dihydroartemisinin-piperaquine or intravenous quinine plus oral quinine for optimum treatment of severe malaria: lesson learnt from a field hospital in Timika, Papua, Indonesia.
    Sikora SA; Poespoprodjo JR; Kenangalem E; Lampah DA; Sugiarto P; Laksono IS; Ahmad RA; Murhandarwati EEH
    Malar J; 2019 Dec; 18(1):448. PubMed ID: 31888655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-treatment haemolysis in African children with hyperparasitaemic falciparum malaria; a randomized comparison of artesunate and quinine.
    Fanello C; Onyamboko M; Lee SJ; Woodrow C; Setaphan S; Chotivanich K; Buffet P; Jauréguiberry S; Rockett K; Stepniewska K; Day NPJ; White NJ; Dondorp AM
    BMC Infect Dis; 2017 Aug; 17(1):575. PubMed ID: 28818049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.